Business

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity

Strategic inventory of 100,000 20-packs now available to meet increasing demand for rapid-onset sublingual caffeine technology ESTERO, FL / ACCESS Newswire / January 22, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a leader in innovative ...

articleAspire Biopharma Holdings, Inc.January 22, 20265/company/aspire-biopharma-inc/news/aspire-biopharma-scales-consumer-division-130000664
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity

About this update from Aspire Biopharma Holdings, Inc.

[{"type":"text","content":"Strategic inventory of 100,000 20-packs now available to meet increasing demand for rapid-onset sublingual caffeine technology","length":126,"tagName":"p"},{"type":"text","content":"ESTERO, FL / ACCESS Newswire / January 22, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a leader in innovative patent-pending sublingual delivery technologies, today announced it has taken delivery of two million units of its flagship caffeine supplement, BUZZ BOMB™.","length":276,"tagName":"p"},{"type":"text","content":"This delivery marks a critical milestone in Aspire's commercialization strategy, introducing a comprehensive brand relaunch and redesigned packaging. The new aesthetic is engineered for high-impact shelf presence and digital engagement, emphasizing the product's core advantages: nearly instant energy, precise 50mg dosing, and the convenience of sublingual absorption.","length":377,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"Aspire Biopharma Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":879,"height":624,"url":"https://media.zenfs.com/en/accesswire.ca/9a597b783eb709f073d7061a729e9c38"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/HTZ_3PICxlsNJGE3Ifg4hQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY4MjtjZj13ZWJw/https://media.zenfs.com/en/accesswire.ca/9a597b783eb709f073d7061a729e9c38","width":879,"height":624},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/URadWlj3s7wghmBtBDWgtg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE3NTg7aD0xMjQ4O2NmPXdlYnA-/https://media.zenfs.com/en/accesswire.ca/9a597b783eb709f073d7061a729e9c38","width":879,"height":624}},"href":"https://app.accessnewswire.com/imagelibrary/4b4a588b-ea80-4d3e-aa9d-a992e9b2482b/image.jpeg","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"BUZZ BOMB™ Newly Designed Packaging","length":35,"tagName":"p"},{"type":"text","content":"Unlike traditional energy drinks or pills, BUZZ BOMB™--a dry powder sprinkled under the tongue from a single-serving stick pack--utilizes a proprietary sublingual format that delivers pure caffeine quickly without the hassle of mixing with water, without drinking typical caffeine sources like energy drinks, coffee, or soda.","length":325,"tagName":"p"},{"type":"text","content":""This significant inventory delivery of BUZZ BOMB™ is expected ...

More updates from Aspire Biopharma Holdings, Inc.

BiopharmaBUZZ BOMBAspiresublingual absorptiondelivery technologyforward-looking statementsenergy drinks